Open Access
Subscription Access
Open Access
Subscription Access
A Prospective Study on assessment of Quality of Prescribing in Patients with Hypertension using Prescription Quality Index (PQI) Tool in a Tertiary Care Hospital
Subscribe/Renew Journal
Objectives: To determine the Quality of Prescribing in Patients with Hypertension using Prescription Quality Index (PQI) Tool. Ensure the Rational Use of Anti-Hypertensive drugs. Methods: Prospective study of Anti-Hypertensive drugs should be conducted on 150 consecutive patients admitted in tertiary care Hospital. The duration of the study will be of 10 months. The prescriptions of the patient who are treated during the course of the study will be audited prospectively using a specially designed form to record the required information. Results: Total of 150 patients 86 were male and 64 were female.This study the age group who receive more Anti Hypertensive drugs are between 56-65 years(40%), In this study who are found with single comorbid condition is (41.3%), Multiple comorbid condition is (22.7%), In This study stages of Hypertension was validated, Pre Hypertensive (88%),Stage 1(57.3%),Stage 2 (34.7%). In This study different classes of drugs commonly used were Diuretics (72%).In the present study it was observed that the higher rates of (56.7%) received dual therapy for Hypertension than mono therapy (43.3%) and compared. Conclusion: Angiotensin II receptor blockers (ARBs) are more effective in slowing the progression of chronic kidney disease (CKD) than other antihypertensive regimens. The PQI is a comprehensive tool which is valid and reliable for measuring quality of prescribing in chronic disease like hypertension in Indian settings. PQI can be used for assessment and comparison of quality of prescribing in different clinical settings at different health care levels.
Keywords
Hypertension, Prescription, Quality Index.
Subscription
Login to verify subscription
User
Font Size
Information
- Hassan nb, ismailhc, naing l, conroyrm, abdulrahman ar. Development and validation of a new prescription quality index. Br j clinpharmacol 2010;70: 500-513.
- Hennessy s, bilker wb, zhou l, weber, brensinger c, wang y. Retrospective drug utilization review, prescribing errors, and clinical outcomes. Jama 2003;290:1494-1499.
- Lagerlov p, hjortdahl p, saxegaard l, andrew m, matheson i. Structuring prescribing data into traffi c-light categories; a tool for evaluating treatment quality in primary care. Fampract 2001;18: 528-533.
- Coste j, venot a. An epidemiologic approach to drug prescribing quality assessment: a study in primary care practice in france. Med care 1999;37:1294-1307.
- Kerr ea, mcglynnea, adams j, keesey j, asch sm. Profi ling the quality of care in twelve communities: results from the cqi study. Health aff (millwood) 2004;23:247-256.
- Liu gg, christensen db. The continuing challenge of inappropriate prescribing in the elderly: update of the evidence. J am pharm assoc (wash) 2002;42:847-857.
- Oborneca, batty gm, maskrey v, swift cg, jackson sh. Development of prescribing indicators for elderly medical inpatients. Br j clinpharmacol 1997;43:91-97.
- Lechevallier-michel n, gautier-bertrand m, alpérovitch a, berr c, belmin j, legrain s, et al; 3c study group. Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3c study. Eur j clinpharmacol 2005;60:813-819.
- Elliott ra, woodward mc, oborne ca. Antithrombotic prescribing in atrial fi brillation: application of a prescribing indicator and multidisciplinary feedback to improve prescribing. Age ageing 2002;31:391-396.
- Ballesteros lc, fernandez san martin mi, sanz cuesta t, escortell mayor e, lopezbilbao c. The cost of inadequate prescriptions for hypolipidaemic drugs. Vicaf group. Pharmacoeconomics 2001; 19:513-522.
Abstract Views: 201
PDF Views: 0